Cell and gene therapies are transforming healthcare with the potential to offer personalized, curative treatments. However, their manufacturing requires specialized processes, stringent quality control, and scalability. This session explores the integration of proven bioprocessing techniques with the unique demands of cell and gene therapy production, addressing key challenges in safety, efficacy, and cost-effectiveness. In this session, you will learn how to:

• Adapt established bioprocessing practices to cell and gene therapy production.
• Overcome challenges in scaling up manufacturing while maintaining quality.
• Ensure robust processes for both clinical and commercial production of individualized therapies.